ConductScience.org, home

Trial · NCT02098733

Results by group59

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Participants With Adverse Drug ReactionsPioglitazone/GlimepirideHypoglycaemia13participants
Number of Participants With Adverse Drug ReactionsPioglitazone/GlimepirideDizziness4participants
Number of Participants With Adverse Drug ReactionsPioglitazone/GlimepirideDysgeusia1participants
Number of Participants With Adverse Drug ReactionsPioglitazone/GlimepirideHeadache1participants
Number of Participants With Adverse Drug ReactionsPioglitazone/GlimepirideHypoaesthesia1participants
Number of Participants With Adverse Drug ReactionsPioglitazone/GlimepirideCardiac failure2participants
Number of Participants With Adverse Drug ReactionsPioglitazone/GlimepirideCardiac failure congestive1participants
Number of Participants With Adverse Drug ReactionsPioglitazone/GlimepiridePleural effusion1participants
Number of Participants With Adverse Drug ReactionsPioglitazone/GlimepirideEructation1participants
Number of Participants With Adverse Drug ReactionsPioglitazone/GlimepirideNausea1participants
Number of Participants With Adverse Drug ReactionsPioglitazone/GlimepirideCholelithiasis1participants
Number of Participants With Adverse Drug ReactionsPioglitazone/GlimepirideDrug eruption1participants
Number of Participants With Adverse Drug ReactionsPioglitazone/GlimepiridePruritus2participants
Number of Participants With Adverse Drug ReactionsPioglitazone/GlimepirideSwelling face1participants
Number of Participants With Adverse Drug ReactionsPioglitazone/GlimepirideUrticaria1participants
Number of Participants With Adverse Drug ReactionsPioglitazone/GlimepirideFace oedema1participants
Number of Participants With Adverse Drug ReactionsPioglitazone/GlimepirideFeeling abnormal1participants
Number of Participants With Adverse Drug ReactionsPioglitazone/GlimepirideHunger2participants
Number of Participants With Adverse Drug ReactionsPioglitazone/GlimepirideOedema7participants
Number of Participants With Adverse Drug ReactionsPioglitazone/GlimepirideOedema peripheral4participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02098733/results